Evotec AG has formed a new integrated drug discovery alliance with LEO Pharma.    The collaboration goal is to generate new leads against innovative targets for a range of dermatological conditions and initially runs for two years. The collaboration leverages Evotec’s hit identification platform including the extensive screening, structural biology and fragment-based drug design capabilities together with LEO Pharma’s track record of drug development and advancing science in ...